Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026
SOUTH SAN FRANCISCO, Calif., May 29, 2026 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with...
Day: May 29, 2026
Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds
BRISBANE, Calif., May 29, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (the “Company”), a clinical-stage biotechnology company developing...
Replimune Announces Planned RP1 BLA Resubmission Following Productive Discussion with FDA
WOBURN, Mass., May 29, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development...
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview
New Taipei City, Taiwan, May 29, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”),...
Dr. Kamalesh Sets New Benchmarks for Urological Surgery in the UAE: Minimally Invasive, Maximum Results!
DUBAI, United Arab Emirates, May 29, 2026 (GLOBE NEWSWIRE) -- Recognized as one of the best urologists in Dubai, Dr....
Glass House Brands Completes Previously Announced Warrant Redemption
LONG BEACH, Calif. and TORONTO, May 29, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the “Company”)...
At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research
Over 30 scientific presentations leverage clonoSEQ MRD testing to assess novel therapies and support MRD-guided patient care across blood cancersSEATTLE,...
Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical
SAN DIEGO and TORONTO, May 29, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC:...
EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy
, May 29, 2026 (GLOBE NEWSWIRE) -- EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth...
Mud Wtr Reviews: Is This Mushroom Coffee Alternative Worth Drinking?
Mud Wtr Reviews: Is This Mushroom Coffee AlternativeWashington dc, May 29, 2026 (GLOBE NEWSWIRE) -- Mud Wtr Reviews: Is This...
Spectral Medical Announces PMA Submission to U.S. FDA for PMX
TORONTO, May 29, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company...
Agios Provides Update on Phase 2b Trial of Tebapivat in Lower-Risk Myelodysplastic Syndromes
Results did not meet predefined threshold to support further development in LR-MDSTebapivat was well tolerated, with no new safety signals...
PICARD MEDICAL, INC. Issues Letter to Shareholders
TUCSON, Ariz., May 29, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the “Company” or “Picard Medical”), parent...
Seer Files ITC Complaint Against Nanomics
Seeks Exclusion Order Barring Importation of Infringing Proteonano Kits and WorkstationsREDWOOD CITY, Calif., May 29, 2026 (GLOBE NEWSWIRE) -- Seer,...
Pharvaris to Present Clinical Data at the EAACI Annual Congress 2026
ZUG, Switzerland, May 29, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2...
Sequana Medical Announces Presentation on Recompensation of Decompensated Cirrhosis Following alfapump® Placement at EASL Congress 2026
Ghent, Belgium, May 29, 2026 (GLOBE NEWSWIRE) -- Post-hoc analysis from the POSEIDON study demonstrates long-term resolution of ascites and...
Gumitide Gummies Under Investigation: Examining Customer Complaints, Ingredients Claims and Serious Side Effects Risk
Gumitide Gummies Scam or Legit: Apple Cider Vinegar and BHB Keto Weight Management Formula, Ingredients, Results, and Refund Terms ExplainedLargo,...
MEDIROM Group Reports Q1 2026 Results
TOKYO, May 28, 2026 (GLOBE NEWSWIRE) -- This report presents an overview of our business performance and key performance indicators...
New Research from ATI Advisory Finds I-SNP Enrollment Associated with Better Outcomes for Long-Term Care Residents
ATI Advisory study, supported by AHCA/NCAL, shows correlation between I-SNP enrollment and lower rates of hospitalization, emergency department visits, and...
Taurus Meds TRT Claims Evaluated: Powerful Testosterone Replacement Therapy & Taurus Charge ED Medication
Online TRT Blood Work Through LabCorp and Quest Diagnostics, Sublingual 4-in-1 ED Medication, Prescription Access, and Pricing ExplainedWilmington, DE, May...